Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Top Cited Papers
- 24 August 2013
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 71, 2-14
- https://doi.org/10.1016/j.addr.2013.08.008
Abstract
No abstract availableKeywords
This publication has 138 references indexed in Scilit:
- Polymeric nanoparticles for drug delivery to the central nervous systemAdvanced Drug Delivery Reviews, 2011
- Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticlesInternational Journal of Pharmaceutics, 2011
- In Vivo Methods to Study Uptake of Nanoparticles into the BrainPharmaceutical Research, 2010
- Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseasesNeurobiology of Disease, 2009
- Functional Protein Delivery into Neurons Using Polymeric NanoparticlesJournal of Biological Chemistry, 2009
- TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugsBiomaterials, 2008
- Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy ratsToxicology Letters, 2008
- Body distribution of 3HH-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after I.V. injections to miceLife Sciences, 2000
- Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticlesResearch in Virology, 1994
- The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer - poloxamine 908Life Sciences, 1987